In this Ask the Expert segment, Dr. Larry Anderson, Jr. of University of Texas Southwest Medical Center answers a question regarding pembrolizumab (Keytruda), anti-PD1 drugs and CAR-T cell therapies as potential treatments for advanced multiple myeloma. Dr. Anderson explains how these treatments work and shares his excitement for future combination therapies.
Get email alerts | http://www.patientpower.info/alerts
Subscribe on YouTube | http://www.youtube.com/patientpower
Like on Facebook | http://www.fb.com/patientpower.info
Follow on Twitter | http://www.twitter.com/patientpower
Follow on Google+ | http://www.google.com/+patientpowerinfo